Ameriprise’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Ameriprise’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-84,424	Closed	-$1.68M	–	4116
2022 Q3	$1.68M	Buy	+84,424	New	+$1.11M	﹤0.01%	2857

Ameriprise's FMTX Position: Q4 2022 in Review

Ameriprise sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 84,424 shares — an estimated $1.68M sold.

Ameriprise first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $1.68M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Ameriprise reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Ameriprise sold 84,424 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.68M.
Ameriprise first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Ameriprise's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.68M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.